Mirati Therapeutics, Inc.

Report date
12/31/2023
Quarter
2023 Q4
Filed
2/12/2024
Shares
124
Value ($000)
7
Weight
0.0%
2020 Q3 - 2023 Q4 (14 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).